Tremblant Capital Group

SEC CIK: 0001353312
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

ALNY holding history

Alnylam Pharmaceuticals, Inc. in every 13F filed by Tremblant Capital Group, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALNY overview All 13F holders of ALNY Full Q2 2026 holdings

Shares (Q2 2026): 92,940
Value: $28.0M
% of portfolio: 0.8%
Quarters held: 3; Since Q4 2025

Holdings of ALNY by Tremblant Capital Group, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	92,940	$28.0M	0.8%	−1,616−1.7%	Reduced	Holders
Q1 2026	94,556	$31.3M	1.0%	−15,576−14.1%	Reduced	Holders
Q4 2025	110,132	$43.8M	1.1%	+110,132	New	Holders